JLab Hear OTC vs Lexie B2 Plus

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.

The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5 in HearAdvisor's lab testing, ranking #7 among 65 OTC devices. Priced at $899, this behind-the-ear rechargeable device has earned back-to-back Expert's Choice Awards in 2023 and 2024. In our testing, the B2 Plus demonstrates strong speech-in-quiet performance at 4.3/5, which is 1.49 points above the OTC category average. Own-voice comfort is excellent at 4.8/5, measuring 2.29 points above average—a notable strength that may appeal to users who find their own voice bothersome with other devices. Speech-in-noise scores 2.1/5, which is above the category average by 0.58 points but remains mixed in absolute terms, reflecting the broader challenge OTC devices face in noisy environments. The device does show a weakness in feedback handling, scoring 2.8/5—which is 1.74 points below the category average of 4.54/5. Users may encounter occasional whistling during activities that bring objects close to the ear. Music streaming performance is mixed at 2.6/5, though still 0.68 points above the OTC average. The Lexie B2 Plus offers both iPhone and Android streaming compatibility. It's well-suited for users prioritizing clear speech in quieter settings and natural own-voice perception, though those frequently in noisy environments or concerned about feedback stability may want to consider alternatives like the Sony CRE-E10 in this price range.